SCHEMBL22036293

SCHEMBL22036293

OCc1cc(CO)c(-c2ccc(C(O)c3cc(CO)c(-c4cc5sccc5s4)cc3-c3cc4sccc4s3)s2)cc1-c1cccs1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20656010 0.77 GPR35 (0.40)
SCHEMBL20656013 0.73 GPR35 (0.41)
SCHEMBL20656009 0.71 DPP4 (0.46) DPP4
SCHEMBL20655986 0.67 DPP4 (0.47) DPP4
SCHEMBL20656011 0.67 GPR35 (0.38) DPP4
SCHEMBL17112945 0.64 GPR35 (0.41) DPP4
SCHEMBL13407287 0.63 DPP4 (0.47) DPP4
SCHEMBL10550712 0.58 DPP4 (0.41) DPP4
SCHEMBL20656175 0.58 GPR35 (0.32)
SCHEMBL14686298 0.57 DPP4 (0.44) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200165266-A1 RING CLOSURE REACTION FLEXENABLE LIMITED (GB) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165266-A1 RING CLOSURE REACTION LIG4, ATG7, RNF4 DPP4 3055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.